Last reviewed · How we verify
NCT05809700
Injection Therapy for Neuropathic Pain
NA trial testing Freshly manufactured 35 kDa hyaluronan fragment in Neuropathic Pain in 36 participants. Completed in 28 July 2023.
12 July 2023
Quick facts
| Lead sponsor | Dove Medical Press Ltd |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 36 |
| Start date | 1 June 2023 |
| Primary completion | 12 July 2023 |
| Estimated completion | 28 July 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- Freshly manufactured 35 kDa hyaluronan fragment — full drug profile →
Conditions studied
- Neuropathic Pain — all drugs for Neuropathic Pain →
Sponsor
Dove Medical Press Ltd — full company profile →
Who can join
Adults 18 to 60, any sex, with Neuropathic Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Shoulder, neck, back and temporal pain and herpes zoster pain are neuropathic pain. Preliminary clinical studies have confirmed that injection of freshly prepared HA35 can relieve neuropathic pain. This clinical study is a prospective repeated experiments. The purpose of this study was to verify the effectiveness of HA35 injection therapy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05809700
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Freshly manufactured 35 kDa hyaluronan fragment
Trials testing the same drug.
- NCT05812300 — Local Injection of Periodontal Pocket Method for the Treatment of Gingivitis · NA · completed
- NCT05810649 — Local Injection for the Treatment of Chronic Wounds and Pain Caused by Chronic Wounds · NA · completed
Other recruiting trials for Neuropathic Pain
Currently open trials in the same condition.
- NCT07493213 — USG-Guided Shoulder Injections in Frozen Shoulder · NA · recruiting
- NCT07493226 — Efficacy of Chemically Distinct Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Pain Phenotypes in Adhesive Capsulitis · NA · recruiting
- NCT06398847 — Virtual Reality (VR) Self-Hypnosis Software · NA · recruiting
- NCT07487610 — Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older · recruiting
- NCT07436806 — SPS Block vs. Surgical Intercostal Block for Chronic Pain After Thoracoscopic Surgery · NA · recruiting
Other Dove Medical Press Ltd trials
Trials by the same sponsor.
- NCT05812300 — Local Injection of Periodontal Pocket Method for the Treatment of Gingivitis · NA · completed
- NCT05765513 — HA35 Treatment the Gingival Discomfort as Well as Gingival Redness and Bleeding of Patients With Periodontitis · NA · completed
- NCT05765526 — A Novel Electrolyzed Water Spray Treatment for the Discomfort or Itching of Patients With Scalp · NA · completed
- NCT05766930 — The Novel Electrolyzed Water Spray Treatment the Genital Itching · NA · completed
- NCT05770258 — The Novel Electrolyzed Water Spray Treatment Mild Periodontitis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05809700 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dove Medical Press Ltd
- Last refreshed: 26 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05809700.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing